IgM anti-protein S antibodies as a risk factor for venous thrombosis

Haematologica

Volumn 93, Issue 7, 2008, Pages 1115-1117

  Borrell, Montserrat ^a   Tirado, Isabel ^a   Mateo, José ^a   Oliver, Artur ^b   Santamaría, Amparo ^a   Fontcuberta, Jordi ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Anti protein S antibodies; Antiphospholipid antibodies; Protein S; Venous thrombosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN S ANTIBODY;

ADULT; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; VEIN THROMBOSIS;

ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; ODDS RATIO; PROTEIN S; RISK; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 46849095145     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12575     Document Type: Letter

References (10)

1. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, et al. Association after linkage analysis indicates that homozygosity for the 46C->T polymorphism in the F 12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004;91:899-904.
2. D'Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi L, Vigano, et al. Autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 1993; 328:1753-7.
3. Levin M, Eley B, Louis J, Cohen H, Young L, Heyderman R. Postinfection purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995;127:355-63.
4. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, et al. Association between the prevalence of antibodies to β2 glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombocytopenic complications. Clinical
5. Bertolaccini ML, Sanna G, Ralhan S, Gennari L, Merrill J, Khamashta M, et al. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003;90:636-41.
6. Nojima J, Kuratsune H, Suehisa E, Kavasaki T, Machii T, Kitani T, et al. Acquired activated protein C resistance associated with anti protein S antibody as a strong risk factor for DVT in non-SLE patients. Throm Haemost 2002;88:716-22.
7. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 2007;110:1178-83.
8. Sorice M, Arcieri P, Griggi T, Circella A, Misasi R, Lenti L, et al. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency. Thromb Haemost 1996;75: 555-9.
9. Guermazi S, Regnault V, Gorgi Y, Ayed K, Lecompte T, Dellagi K. Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus. Blood Coagul Fibrinolylis 2000;11:491-8.
10. Regnault V, Boehlen F, Ozsahin H, Wahl D, de Groot P, Lecompte T, et al. Antiprotein S antibodies following a varicella infection: detection, characterisation and influence on thrombin generation. J Thromb Haemost 2005;3:1243-9.